ArticleAmerican journal of cancer research2026

Efficacy and safety analysis of a novel BTK inhibitor in patients with mantle cell lymphoma harboring TP53 mutations.

Min Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.